companydata.dkPerfusion Tech ApS: Financial statements 2021
CVR: 38238213
Perfusion Tech ApS (CVR 38238213) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,066,804 and a net result of DKK -2,117,687 compared with DKK -1,485,658 the year before. Equity amounted to DKK -3,932,376. The company had 4 employees in the financial year.
- Gross Profit
- -1,066,804 kr.
- Profit/Loss
- -2,117,687 kr.
- Equity
- -3,932,376 kr.
- Total Assets
- 1,264,197 kr.
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -1.1 mio. | -2.1 mio. | -3.9 mio. | 4 |
| 2020 | - | -1.1 mio. | -1.5 mio. | -1.8 mio. | 3 |
| 2019 | - | -539 t. | -596 t. | -329 t. | 1 |
| 2018 | - | -262 t. | -238 t. | -453 t. | - |
| 2017 | - | -278 t. | -272 t. | -214 t. | - |
Find more companies like Perfusion Tech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Perfusion Tech ApS has published its annual report for 2020. Gross profit came to DKK -1,092,073, and the net result was DKK -1,485,658.
About Perfusion Tech ApS
Perfusion Tech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Perfusion Tech IVS. The management consists of Declan Cassells. The company is owned by Renew Pharmaceuticals Limited. In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity amounted to DKK -9,640,655.